Stroes, Erik S |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
NCT06383390: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) |
|
|
| Recruiting | 3 | 10000 | Europe, Canada, US, RoW | Retatrutide, LY3437943, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD) | 02/29 | 02/29 | | |
| Recruiting | 2 | 110 | Europe | Icosapent ethyl, Placebo | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Aortic Valve Stenosis | 07/26 | 12/26 | | |
KRAKEN, NCT05563246: A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events |
|
|
| Completed | 2 | 233 | Europe, Japan, US, RoW | LY3473329, Placebo | Eli Lilly and Company | Lipoprotein Disorder | 03/24 | 03/24 | | |
| Completed | N/A | 135 | Europe | Coronary computed tomography angiography (CCTA) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Dutch Heart Foundation | Familial Hypercholesterolemia | 12/22 | 12/22 | | |
| Completed | N/A | 41 | Europe | 68Ga-Dotatate PET/CT | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Atheroscleroses, Coronary | 10/23 | 10/23 | | |
| Recruiting | N/A | 60 | Europe | | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Coronary Artery Disease Progression | 12/26 | 04/27 | | |
| Active, not recruiting | N/A | 310 | Europe | | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Coronary Artery Disease Progression | 07/26 | 12/26 | | |
Kelder, Hans |
No trials found |